Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find out what to include in a balanced crypto investment. Create a diversified portfolio that aligns with your investment goals.
23,214 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Major indices surge as news of a potential Iran peace framework reduces geopolitical risk. Oil slides below $100, eas...
A contrarian take on the tech sell-off. Learn why durable AI and cloud trends could spark a rebound and how to positi...
UBS lifts industries $140 price target on CF Industries as nitrogen markets tighten amid supply disruptions. The move...
A 14-year-old freshman at Stowe High School has filed to run for Vermont governor, becoming the first under-18 candid...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Tesla stock jumps about 19% in the past month, renewing the old Sell in May debate as summer trading looms and moment...
A hantavirus outbreak unfolds, missing a coordinated federal response, leaving travelers and insurers scrambling for ...
Arm Holdings’ stock has jumped sharply this year on AI data center demand, yet a valuation gap and monetization hurdl...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...